Literature DB >> 14674253

Phosphoprotein inhibitors of protein phosphatase-1.

Masumi Eto1, Craig Leach, Nikolaos A Tountas, David L Brautigan.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14674253     DOI： 10.1016/s0076-6879(03)66019-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  4 in total

1.  Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Authors:  Masumi Eto; Toshio Kitazawa; Fumiko Matsuzawa; Sei-Ichi Aikawa; Jason A Kirkbride; Noriyoshi Isozumi; Yumi Nishimura; David L Brautigan; Shin-Ya Ohki
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

2.  Identification of the interaction sites of Inhibitor-3 for protein phosphatase-1.

Authors:  Lifang Zhang; Zhiqing Qi; Yan Gao; Ernest Y C Lee
Journal:  Biochem Biophys Res Commun       Date:  2008-10-23       Impact factor: 3.575

3.  Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction.

Authors:  Alexander Khromov; Nandini Choudhury; Andra S Stevenson; Avril V Somlyo; Masumi Eto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

4.  Inhibitor-2 induced M-phase arrest in Xenopus cycling egg extracts is dependent on MAPK activation.

Authors:  Arian Khandani; Mahmood Mohtashami; Anne Camirand
Journal:  Cell Mol Biol Lett       Date:  2011-09-26       Impact factor: 5.787
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.